JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Barrington Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Cross Country Healthcare Is Maintained at Market Perform by Barrington Research
Cross Country Healthcare Price Target Maintained With a $18.61/Share by Barrington Research
Cross Country Healthcare Analyst Ratings
Hold Rating Maintained for Cross Country Healthcare Amidst Profitability Decline and Pending Aya Healthcare Merger
Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edgewise Therapeutics (EWTX) and Cross Country Healthcare (CCRN)
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Raises Target Price to $18.61
JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
William Blair Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
William Blair Keeps Their Hold Rating on Cross Country Healthcare (CCRN)
William Blair Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Cross Country Healthcare (CCRN)
Cross Country Healthcare Analyst Ratings
Cross Country Healthcare (CCRN) Gets a Hold From Truist Financial
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Barrington Downgrades Cross Country Healthcare(CCRN.US) to Hold Rating, Cuts Target Price to $18.61
Hold Rating Recommended for Cross Country Healthcare Amid Acquisition by Aya Healthcare